Pathomorphological picture: what happens to the organ
Liver cirrhosis is not just inflammation, but a fundamental morphological catastrophe. The pathological process is based on a classical triad of structural changes that make the disease irreversible:
- Diffuse sclerosis (fibrosis): connective tissue begins to actively proliferate throughout the organ volume, forming a dense framework of scars.
- Nodular transformation: the normal lobular architecture of the liver is completely destroyed. In place of healthy lobules, pathological regeneration nodules form that are incapable of fully performing the organ's functions.
- Neoangiogenesis: abnormal formation of new intrahepatic vascular anastomoses occurs, which critically alters hemodynamics and contributes to the development of complications.
How we assess fibrosis: from laboratory tests to the gold standard
The assessment of liver tissue state is divided into invasive and non-invasive technologies. The main problem with routine biochemistry is that standard enzymes (ALT and AST) do not correlate at all with the actual stage of fibrosis and the severity of histological changes.
- Specific panels: To adequately assess the activity of fibrogenesis, commercial tests are used (e.g., FibroTest, ActiTest). They analyze a combination of acute-phase proteins and biochemical markers.
- Non-invasive imaging: Basic methods include ultrasound, spiral CT, MRI, and magnetic resonance elastography. However, fibroelastometry (the FibroScan device) has become the fastest and most widespread tool. The method allows for a reliable assessment of tissue stiffness and determination of the fibrosis stage from F0 (normal) to F4/F5 (established cirrhosis).
- Punch biopsy: The traditional "gold standard". The obtained biopsy specimen is evaluated digitally using semiquantitative scales (Knodell, Ishak, METAVIR, Desmet) to provide a standardized description of the inflammatory activity index and the degree of sclerosis. Important: in pediatrics, indications for biopsy are strictly limited. It is prescribed exclusively in situations where non-invasive methods fail to establish an accurate diagnosis.
Principles of therapy and management of complications
If a child is diagnosed with compensated cirrhosis, the physician's key task is to confirm the diagnosis as early as possible and initiate etiotropic therapy aimed at eliminating the cause of the disease (if such treatment exists for the given nosology in principle).
When syndromic complications develop, the strategy shifts to preventing life-threatening conditions:
- Management of ascites: The cornerstone of treatment is diet therapy with strict sodium restriction (no more than 2 g of salt per day). Diuretics are prescribed pharmacologically. If baseline diuretic therapy yields no response, intravenous human albumin administration is indicated to correct oncotic pressure.
- Portal hypertension: The main danger is bleeding from esophageal varices (EV). Non-selective beta-blockers (propranolol) are used for their prevention. If acute bleeding has already begun, emergency surgical or endoscopic measures are required: band harvesting, variceal ligation, or sclerotherapy.
- Hepatic encephalopathy: To reduce the production of neurotoxic ammonia, the protein quota in the diet is cut down to 1.0–1.5 g/kg of body weight per day. Among medications, lactulose is used, which binds and excretes toxic metabolites through the intestines.
When the process progresses to the decompensation stage, conservative medicine exhausts its capabilities. Liver transplantation becomes the only radical and effective method to save the child.
Autoimmune conditions as a cause of cirrhosis
A distinct group worth highlighting is autoimmune diseases, which often lead to severe damage to the hepatobiliary tract. This category traditionally includes primary sclerosing cholangitis (PSC), primary biliary cholangitis/cirrhosis (PBC), and autoimmune hepatitis (AIH).
For the diagnosis of AIH, the key marker is the detection of specific autoantibodies in the patient's blood serum. Thus, the serological profile of type 1 autoimmune hepatitis is characterized by elevated titers of antinuclear antibodies (ANA) and anti-smooth muscle antibodies (SMA).
The abbreviation FUN will help you remember the pathomorphological triad of cirrhosis: Fibrosis (diffuse proliferation of connective tissue), Uniform/nodular transformation of lobules (nodular transformation), Neoangiogenesis (formation of vascular shunts).
Class and exam questions
Can the severity of liver cirrhosis be determined solely by ALT and AST levels?
No. Standard liver enzymes do not correlate with the actual stage of fibrosis and histological changes. This requires specific biochemical panels (ActiTest, FibroTest).
In what cases is a percutaneous liver biopsy performed in a child?
In pediatrics, biopsy is performed extremely rarely. This is justified only when modern non-invasive technologies (such as fibroelastometry) fail to establish an accurate diagnosis and evaluate the organ's structure.
How is diet adjusted in hepatic encephalopathy?
To reduce the production of toxic ammonia, the child's protein intake is strictly restricted to 1.0–1.5 grams per kilogram of body weight per day.
What should be done if ascites in cirrhosis does not respond to diuretics?
In the absence of a response to baseline diuretic therapy, the patient is indicated for intravenous administration of human albumin to restore oncotic pressure.
What else to study on this topic
- Semiquantitative histological scales: Knodell, Ishak, METAVIR, Desmet
- Principles of interpreting fibroelastometry results (F0–F5 scale)
- Pathogenesis and serological diagnosis of type 1 autoimmune hepatitis
- Endoscopic methods for stopping esophageal variceal bleeding
- Indications and contraindications for liver transplantation in pediatrics
Master the entire topic in the Pediatrics course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Liver cirrhosis in children" and 3,738 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 71 video lessons on the subject
Other topics in "Chapter 7. Digestive System Diseases"
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.